Skip to content


Revex, Selincro (nalmefene) is a small molecule pharmaceutical. Nalmefene was first approved as Revex on 1995-04-17. It is used to treat drug overdose, opioid-related disorders, and respiration disorders in the USA. It has been approved in Europe to treat alcohol-related disorders. The pharmaceutical is active against mu-type opioid receptor and kappa-type opioid receptor. In addition, it is known to target delta-type opioid receptor.
Trade Name Selincro
Common Name Nalmefene
Indication alcohol-related disorders, drug overdose, opioid-related disorders, respiration disorders
Drug Class Narcotic agonists/antagonists (normorphine type)
Get full access now